Condition: Ischemic Stroke · Delirium · Cognitive Impairment · Sponsor: Universitair Ziekenhuis Brussel
Primary objective of this study: determine whether PSD is a risk factor for PSCI, independent of brain frailty and premorbid cognitive functioning. Secondary objectives: 1. to investigate the role of infarct location, imaging markers of brain frailty and brain network disintegration in the development of PSD; 2. to investigate the role of persistent brain network disintegration in the development of PSCI.
This description comes directly from the study's public registry record.
Fenne Vandervorst, MD · 024776801 · fenne.vandervorst@uzbrussel.be
Karen Vandaele · 024776801 · karen.vandaele@uzbrussel.be
Always discuss trial participation with your own doctor first.
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06650436